Correlation Between Akari Therapeutics and Catalyst Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Akari Therapeutics and Catalyst Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akari Therapeutics and Catalyst Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akari Therapeutics PLC and Catalyst Biosciences, you can compare the effects of market volatilities on Akari Therapeutics and Catalyst Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akari Therapeutics with a short position of Catalyst Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akari Therapeutics and Catalyst Biosciences.

Diversification Opportunities for Akari Therapeutics and Catalyst Biosciences

-0.8
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Akari and Catalyst is -0.8. Overlapping area represents the amount of risk that can be diversified away by holding Akari Therapeutics PLC and Catalyst Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Catalyst Biosciences and Akari Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akari Therapeutics PLC are associated (or correlated) with Catalyst Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Catalyst Biosciences has no effect on the direction of Akari Therapeutics i.e., Akari Therapeutics and Catalyst Biosciences go up and down completely randomly.

Pair Corralation between Akari Therapeutics and Catalyst Biosciences

If you would invest  41.00  in Catalyst Biosciences on August 25, 2024 and sell it today you would earn a total of  0.00  from holding Catalyst Biosciences or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy4.55%
ValuesDaily Returns

Akari Therapeutics PLC  vs.  Catalyst Biosciences

 Performance 
       Timeline  
Akari Therapeutics PLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Akari Therapeutics PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Catalyst Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Catalyst Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy forward indicators, Catalyst Biosciences is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Akari Therapeutics and Catalyst Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Akari Therapeutics and Catalyst Biosciences

The main advantage of trading using opposite Akari Therapeutics and Catalyst Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akari Therapeutics position performs unexpectedly, Catalyst Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Catalyst Biosciences will offset losses from the drop in Catalyst Biosciences' long position.
The idea behind Akari Therapeutics PLC and Catalyst Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Commodity Directory
Find actively traded commodities issued by global exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals